These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2942458)

  • 1. Susceptibility of Haemophilus ducreyi to spectinomycin in vitro.
    Hafiz S; Jones BM; Kinghorn GR; Duerden BI
    Genitourin Med; 1986 Aug; 62(4):251-2. PubMed ID: 2942458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of Haemophilus ducreyi to ampicillin and sulbactam in vitro.
    Jones BM; Hafiz S; Duerden BI
    Antimicrob Agents Chemother; 1986 Jun; 29(6):1110-2. PubMed ID: 3015016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activities of U-63366, a spectinomycin analog; roxithromycin (RU 28965), a new macrolide antibiotic; and five quinolone derivatives against Haemophilus ducreyi.
    Sanson-Le Pors MJ; Casin IM; Thebault MC; Arlet G; Perol Y
    Antimicrob Agents Chemother; 1986 Sep; 30(3):512-3. PubMed ID: 2946262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility and characterization of outer membrane proteins of Haemophilus ducreyi isolated in Thailand.
    Taylor DN; Echeverria P; Hanchalay S; Pitarangsi C; Slootmans L; Piot P
    J Clin Microbiol; 1985 Mar; 21(3):442-4. PubMed ID: 3872313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Etest with agar dilution for antimicrobial susceptibility testing of Haemophilus ducreyi.
    Lagergård T; Frisk A; Trollfors B
    J Antimicrob Chemother; 1996 Nov; 38(5):849-52. PubMed ID: 8961054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of Haemophilus ducreyi. A study.
    Sng EH; Lim AL; Rajan VS; Goh AJ
    Br J Vener Dis; 1982 Aug; 58(4):239-42. PubMed ID: 6980682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic susceptibilities and plasmid profiles of Haemophilus ducreyi isolates from southern Africa.
    Abeck D; Johnson AP; Dangor Y; Ballard RC
    J Antimicrob Chemother; 1988 Oct; 22(4):437-44. PubMed ID: 3264554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of 40 Haemophilus ducreyi strains to 34 antimicrobial products.
    Slootmans L; Vanden Berghe DA; Van Dyck E; Piot P
    Antimicrob Agents Chemother; 1983 Oct; 24(4):564-7. PubMed ID: 6606394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibilities of southern African isolates of Haemophilus ducreyi.
    Dangor Y; Miller SD; Exposto Fda L; Koornhof HJ
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1458-60. PubMed ID: 3264133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antimicrobial susceptibility patterns of fifty-seven strains of Haemophilus ducreyi isolated in Amsterdam from 1978 to 1985.
    Sturm AW
    J Antimicrob Chemother; 1987 Feb; 19(2):187-91. PubMed ID: 3494720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility of Haemophilus ducreyi.
    Hammond GW; Lian CJ; Wilt JC; Ronald AR
    Antimicrob Agents Chemother; 1978 Apr; 13(4):608-12. PubMed ID: 307364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of Haemophilus ducreyi to several antibiotics.
    Ismaeel NA
    Microbios; 1993; 74(299):103-9. PubMed ID: 8361391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chancroid with a single dose of spectinomycin.
    Guzmán M; Guzmán J; Bernal M
    Sex Transm Dis; 1992; 19(5):291-4. PubMed ID: 1411847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of spectinomycin and erythromycin in the treatment of chancroid.
    Ballard RC; da L'Exposto F; Dangor Y; Fehler HG; Miller SD; Koornhof HJ
    J Antimicrob Chemother; 1990 Sep; 26(3):429-34. PubMed ID: 2146242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the in vitro activities of various parenteral and oral antimicrobial agents against endemic Haemophilus ducreyi.
    Aldridge KE; Cammarata C; Martin DH
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1986-8. PubMed ID: 8239617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sensitivity of Neisseria gonorrhoeae to spectinomycin].
    Neubert U; Ruckdeschel G
    Hautarzt; 1981 Apr; 32(4):179-81. PubMed ID: 6453109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparative in-vitro activity of twelve 4-quinolone antimicrobials against Haemophilus ducreyi.
    Wall RA; Mabey DC; Bello CS; Felmingham D
    J Antimicrob Chemother; 1985 Aug; 16(2):165-8. PubMed ID: 3877717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the in vitro activity of rosamicin, erythromycin, clindamycin, metroidazole and ornidazole against Haemophilus ducreyi, including beta-lactamase producing strains.
    Feltham S; Ronald AR; Albritton WL
    J Antimicrob Chemother; 1979 Nov; 5(6):731-4. PubMed ID: 317079
    [No Abstract]   [Full Text] [Related]  

  • 19. [Spectinomycin sensitivity of Neisseria gonorrhoeae].
    Näher H; Pekar U; Petzoldt D
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Oct; 266(3-4):522-5. PubMed ID: 2964157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of Haemophilus ducreyi to spermicidal compounds, in vitro.
    Jones BM; Geary I; Lee ME; Duerden BI
    Genitourin Med; 1991 Jun; 67(3):268-9. PubMed ID: 2071133
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.